Ignite Creation Date:
2025-12-25 @ 12:19 AM
Ignite Modification Date:
2026-01-02 @ 9:15 AM
Study NCT ID:
NCT05507658
Status:
COMPLETED
Last Update Posted:
2025-11-28
First Post:
2022-08-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Tislelizumab Combined With XELOX as Neoadjuvant Therapy for G/GEJ Adenocarcinoma
Sponsor:
Xijing Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-07-18
Start Date Type:
ACTUAL
Primary Completion Date:
2023-07-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-10-10
Completion Date Type:
ACTUAL
First Submit Date:
2022-08-17
First Submit QC Date:
None
Study First Post Date:
2022-08-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-23
Last Update Post Date:
2025-11-28
Last Update Post Date Type:
ESTIMATED